ASPN
Aspen Aerogels, Inc.
ASPN's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over ASPN overall, supported by stronger valuation and stronger fundamentals.
ASPN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Strong |
ASPN's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
ASPN PE Valuation
ASPN has no meaningful PE right now: it lost money over the past year.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
ASPN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect ASPN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
ASPN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.57 | +$2.14 |
| Q2 2026 | -$1.52 | +$2.28 |
| Q1 2026 | -$1.35 | +$2.13 |
| Q4 2025 | -$4.73 | -2882% |
| Q3 2025 | -$3.71 | -37200% |
| Q2 2025 | -$3.80 | -$3.79 |
| Q1 2025 | -$3.48 | -$3.04 |
| Q4 2024 | $0.17 | +$0.83 |
ASPN lost $1.57 per share over the past year, a smaller loss than the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over ASPN on earnings quality, reporting a profit while its opponent remains loss making.
ASPN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $85.2M | +17% |
| Q2 2026 | $49.8M | -36% |
| Q1 2026 | $37.9M | -52% |
| Q4 2025 | $41.3M | -66% |
| Q3 2025 | $73M | -38% |
| Q2 2025 | $78M | -34% |
| Q1 2025 | $78.7M | -17% |
| Q4 2024 | $123.1M | +46% |
ASPN's revenue is recovering but still below its 2024 peak: $85M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.4% | -3.8 points |
| Q2 2026 | -58% | -51 points |
| Q1 2026 | -55% | +325 points |
| Q4 2025 | -170% | -182 points |
| Q3 2025 | -4.6% | -19 points |
| Q2 2025 | -6.6% | -24 points |
| Q1 2025 | -380% | -383 points |
| Q4 2024 | 12% | +10 points |
ASPN's operating margin was −8.4% last quarter, down 3.8 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over ASPN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over ASPN on profitability, with a higher operating margin.
ASPN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.5M | -243% |
| Q2 2026 | -$18M | -$1.2M |
| Q1 2026 | $32.8M | +$40.1M |
| Q4 2025 | $13.7M | -35% |
| Q3 2025 | $5.9M | +$6M |
| Q2 2025 | -$16.8M | +$1.2M |
| Q1 2025 | -$7.4M | +$36.2M |
| Q4 2024 | $20.9M | +$51.5M |
ASPN has burned cash in most quarters: $20M over the past year, about seven times what it generated the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over ASPN on cash flow, with more consistent year-over-year improvement.
ASPN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
ASPN has more cash than debt.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
ASPN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 33.1 | Neutral |
ASPN's weekly RSI is 58 (neutral) and its Stochastic is 33 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
ASPN PE vs Industrials Sector
| Metric | ASPN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ASPN has no meaningful PE right now: it lost money over the past year.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
ASPN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 11% above |
| 20 week MA | $5.28 | 13% above |
| 50 week MA | $4.53 | 32% above |
| 100 week MA | $5.97 | 0.3% above |
| 200 week MA | $10.3 | 42% below |
ASPN has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
ASPN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.74 | $17.7 | +129% |
| 2021 | $17.7 | $50.8 | +187% |
| 2022 | $50.8 | $11.6 | -77% |
| 2023 | $11.6 | $15.8 | +36% |
| 2024 | $15.8 | $12.5 | -21% |
| 2025 | $12.5 | $2.94 | -76% |
| 2026 YTD | $2.94 | $5.99 | +104% |
ASPN has the edge over VRT on returns for 2026, with the stronger performance.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT's yearly returns have swung widely, from +275% in 2023 to −48% in 2022. It's up 25% so far in 2026.